Pacer Advisors, Inc. Bridge Bio Pharma, Inc. Transaction History

Pacer Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$23.0 - $31.04 $1,656 - $2,234	72 Added 4.89%	1,545 $39,000
Q1 2024 May 10, 2024	BUY	$27.35 - $40.45 $40,286 - $59,582	1,473 New	1,473 $45,000
Q2 2021 Jul 21, 2021	SELL	$46.47 - $63.93 $51,256 - $70,514	-1,103 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$55.47 - $72.35 $57,910 - $75,533	-1,044 Reduced 48.63%	1,103 $68,000
Q4 2020 Jan 20, 2021	SELL	$38.38 - $71.11 $58,260 - $107,944	-1,518 Reduced 41.42%	2,147 $153,000
Q3 2020 Oct 19, 2020	BUY	$27.2 - $42.19 $99,688 - $154,626	3,665 New	3,665 $138,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.